Angela Kulesza
Family · Tewksbury, MANPI 1235107210
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,237 of the $16,297 with a category attached, or 75.1%. 49 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 27.8% of the total. Reporting peaked in 2021 at $6,595 and has fallen 53.3% since, to $3,080 in 2025. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 620 payments — averaging $26.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$5K
- AbbVie$2K
- AstraZeneca$1K
- Pfizer$1K
- Bayer$944
- E.r. Squibb & Sons, L.L.C.$656
- plus $6K from 43 others
What the payments were for
- Speaking & faculty fees$3,97524%
- Food & beverage$12,23775%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,297 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 132 | $133,067 |
| EliquisApixaban | 64 | $64,896 |
| FarxigaDapagliflozin Propanediol | 68 | $51,022 |
| TrulicityDulaglutide | 42 | $48,302 |
| RybelsusSemaglutide | 27 | $45,230 |
| JanuviaSitagliptin Phosphate | 44 | $43,259 |
| OzempicSemaglutide | 44 | $42,399 |
| OxycontinOxycodone Hcl | 28 | $39,317 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $26,741 |
| TradjentaLinagliptin | 24 | $19,767 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $18,837 |
| LinzessLinaclotide | 19 | $17,325 |
| RexultiBrexpiprazole | 11 | $16,173 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $13,926 |
| MyrbetriqMirabegron | 16 | $12,522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $114 | $158,842168 claims |
| Novo NordiskRybelsus, Ozempic | $472 | $87,62971 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,394 | $69,85896 claims |
| PfizerEliquis | $1,177 | $64,89664 claims |
| Lilly USA, LLCTrulicity | $314 | $48,30242 claims |
| MerckJanuvia | $421 | $43,25944 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $343 | $35,15255 claims |
| AbbVieLinzess | $1,779 | $17,32519 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $380 | $16,17311 claims |
| Astellas Pharma US IncMyrbetriq | $293 | $12,52216 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $30 | $10,58319 claims |
| BayerKerendia | $944 | $10,09912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,320 family providers in Massachusetts.
Other family in Tewksbury
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
- Marissa CasilloFoxborough$31K
- Rochelle NazarianDanvers$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.